Organised by EARTO & EIRMA - Hosted by Luxembourg Institute of Science andd Technology (LIST)
Chris Shilling is an independent consultant providing innovation project management and planning services to pharmaceutical and medical device companies, and Public Private Partnerships.
After training in the UK as a lawyer, Chris worked for several years as a professional musician and then managed the document collection for SCA’s innovative paper machine construction project in Kent, England. In 1997 he joined Pfizer’s Global R&D division, leading knowledge and information systems projects to support senior management, drug R&D teams and two large mergers. His last role was to manage a group reporting to the R&D and Commercial Leadership, conducting research into business model innovation.
Chris became an independent consultant in 2007, and has managed innovation and business planning projects for a range of start-ups, SMEs, large companies and PPPs, including Amarin, DDMoRe (an IMI project), DNDi, Lumithera, PHTI and PharmaDiagnostics. Following a year long engagement in 2010 for Novartis’ Pricing & Reimbursement global group in Basel, Chris has continued to provide research services to Akceso Advisors, a specialist consulting company in the field of drug pricing, reimbursement & market access. He is also a consulting advisor to i2e Consulting, a world leader in developing business Apps for mobile devices. Chris chairs EIRMA’s Programme Planning Committee.